2型糖尿病患者皮下脂肪面积与空腹C肽水平的相关性研究(5)
[15] Wahren J. C-peptide and the pathophysiology of microvascular complications of diabetes [J]. J Intern Med,2017, 281(1):3-6.
[16] Pujia A,Gazzaruso C,Montalcini T. An update on the potential role of C-peptide in diabetes and osteoporosis [J]. Endocrine,2017,58(3):408-412.
[17] Pinger CW,Entwistle KE,Bell TM,et al. C-Peptide replacement therapy in type 1 diabetes: are we in the trough of disillusionment? [J]. Mol Biosyst,2017,13(8):1432-1437.
[18] Wahren J,Larsson C. C-peptide:new findings and therapeutic possibilities [J]. Diabetes Res Clin Pract,2015, 107(3):309-319.
[19] He G,Pedersen SB,Bruun JM,et al. Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects [J]. Horm Metab Res,2003,35(3):178-182.
[20] Li H,Wu G,Fang Q,et al. Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat [J]. Nat Commun,2018,9(1):272.
[21] Cnop M,Landchild MJ,Vidal J,et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations:distinct metabolic effects of two fat compartments [J]. Diabetes,2002,51(4):1005-1015.
(收稿日期:2020-03-05 本文編辑:顾家毓), 百拇医药(刘思默 柯静 安雅欣 赵冬)
[16] Pujia A,Gazzaruso C,Montalcini T. An update on the potential role of C-peptide in diabetes and osteoporosis [J]. Endocrine,2017,58(3):408-412.
[17] Pinger CW,Entwistle KE,Bell TM,et al. C-Peptide replacement therapy in type 1 diabetes: are we in the trough of disillusionment? [J]. Mol Biosyst,2017,13(8):1432-1437.
[18] Wahren J,Larsson C. C-peptide:new findings and therapeutic possibilities [J]. Diabetes Res Clin Pract,2015, 107(3):309-319.
[19] He G,Pedersen SB,Bruun JM,et al. Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects [J]. Horm Metab Res,2003,35(3):178-182.
[20] Li H,Wu G,Fang Q,et al. Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat [J]. Nat Commun,2018,9(1):272.
[21] Cnop M,Landchild MJ,Vidal J,et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations:distinct metabolic effects of two fat compartments [J]. Diabetes,2002,51(4):1005-1015.
(收稿日期:2020-03-05 本文編辑:顾家毓), 百拇医药(刘思默 柯静 安雅欣 赵冬)